{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:11:58Z","timestamp":1769940718496,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,12]]},"DOI":"10.7759\/cureus.71325","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T22:57:03Z","timestamp":1728773823000},"source":"Crossref","is-referenced-by-count":1,"title":["Vonoprazan-Associated Mucosal Redness: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Masaya","family":"Iwamuro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumasa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0368-z","article-title":"Vonoprazan: first global approval","volume":"75","author":"Garnock-Jones KP","year":"2015","unstructured":"Garnock-Jones KP. Vonoprazan: first global approval. Drugs. 2015, 75:439-43. 10.1007\/s40265-015-0368-z","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0326-7","article-title":"The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations","volume":"55","author":"Echizen H","year":"2016","unstructured":"Echizen H. The first-in-class potassium-competitive acid blocker, vonoprazan fumarate: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 2016, 55:409-18. 10.1007\/s40262-015-0326-7","journal-title":"Clin Pharmacokinet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0345-2","article-title":"Characteristics of the novel potassium-competitive acid blocker vonoprazan fumarate (TAK-438)","volume":"33","author":"Otake K","year":"2016","unstructured":"Otake K, Sakurai Y, Nishida H, et al.. Characteristics of the novel potassium-competitive acid blocker vonoprazan fumarate (TAK-438). Adv Ther. 2016, 33:1140-57. 10.1007\/s12325-016-0345-2","journal-title":"Adv Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5009\/gnl20036","article-title":"Proton pump inhibitor-related gastric mucosal changes","volume":"15","author":"Kim GH","year":"2021","unstructured":"Kim GH. Proton pump inhibitor-related gastric mucosal changes. Gut Liver. 2021, 15:646-52. 10.5009\/gnl20036","journal-title":"Gut Liver"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/deo2.400","article-title":"Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy","volume":"5","author":"Shinozaki S","year":"2025","unstructured":"Shinozaki S, Osawa H, Miura Y, et al.. Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy. DEN Open. 2025, 5:e400. 10.1002\/deo2.400","journal-title":"DEN Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2023.279","article-title":"Potassium-competitive acid blocker-associated gastric mucosal lesions","volume":"57","author":"Kubo K","year":"2024","unstructured":"Kubo K, Kimura N, Kato M. Potassium-competitive acid blocker-associated gastric mucosal lesions. Clin Endosc. 2024, 57:417-23. 10.5946\/ce.2023.279","journal-title":"Clin Endosc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i16.2220","article-title":"Drug-induced mucosal alterations observed during esophagogastroduodenoscopy","volume":"30","author":"Iwamuro M","year":"2024","unstructured":"Iwamuro M, Kawano S, Otsuka M. Drug-induced mucosal alterations observed during esophagogastroduodenoscopy. World J Gastroenterol. 2024, 30:2220-32. 10.3748\/wjg.v30.i16.2220","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-010-0207-7","article-title":"Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan","volume":"45","author":"Hongo M","year":"2010","unstructured":"Hongo M, Fujimoto K. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010, 45:618-24. 10.1007\/s00535-010-0207-7","journal-title":"J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000518292","article-title":"Vonoprazan-associated gastric mucosal redness in non-Helicobacter pylori-infected and Helicobacter pylori-eradicated stomach","volume":"15","author":"Kubo K","year":"2021","unstructured":"Kubo K, Kimura N, Watanabe R, Higashino M, Tsuda M, Kato M. Vonoprazan-associated gastric mucosal redness in non-Helicobacter pylori-infected and Helicobacter pylori-eradicated stomach. Case Rep Gastroenterol. 2021, 15:751-8. 10.1159\/000518292","journal-title":"Case Rep Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3715-19","article-title":"Vonoprazan-associated gastric mucosal redness: a report of four cases","volume":"59","author":"Kubo K","year":"2019","unstructured":"Kubo K, Kimura N, Matsuda S, Tsuda M, Mabe K, Kato M. Vonoprazan-associated gastric mucosal redness: a report of four cases. Intern Med. 2019, 59:507-11. 10.2169\/internalmedicine.3715-19","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304577-vonoprazan-associated-mucosal-redness-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T22:57:04Z","timestamp":1728773824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304577-vonoprazan-associated-mucosal-redness-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.71325","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,12]]}}}